Racial and Ethnic Representation in Clinical Trials of Janus Kinase Inhibitors for Dermatologic Conditions: A Systematic Review
Journal of Drugs in Dermatology · 2026-04-01 · 25 (4) · 316-323
DOI: 10.36849/jdd.9441 ↗At a glance
Systematische Übersicht in Journal of Drugs in Dermatology, published online on 2026-03-01. Written by Christine Olagun-Samuel and 6 co-authors. Major MEDLINE topics: Janus Kinase Inhibitors, Skin Diseases, Clinical Trials as Topic, Ethnicity.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
MeSH terms (MEDLINE)
Substances
Cite
APA
Olagun-Samuel, C., Ansah, M. A., Shakelly, P., Sherali, N., Ologunebi, A., Sicco, K. L., & Adotama, P. (2026). Racial and Ethnic Representation in Clinical Trials of Janus Kinase Inhibitors for Dermatologic Conditions: A Systematic Review. Journal of Drugs in Dermatology, 25(4), 316-323. https://doi.org/10.36849/jdd.9441
Vancouver
Olagun-Samuel C, Ansah MA, Shakelly P, Sherali N, Ologunebi A, Sicco KL, et al. Racial and Ethnic Representation in Clinical Trials of Janus Kinase Inhibitors for Dermatologic Conditions: A Systematic Review. Journal of Drugs in Dermatology. 2026;25(4):316-323. doi:10.36849/jdd.9441
BibTeX
@article{OlagunSamuel2026,
author = {Olagun-Samuel, Christine and Ansah, Maame-Afua and Shakelly, Purvi and Sherali, Nabiha and Ologunebi, Aminat and Sicco, Kristen Lo and Adotama, Prince},
title = {Racial and Ethnic Representation in Clinical Trials of Janus Kinase Inhibitors for Dermatologic Conditions: A Systematic Review},
journal = {Journal of Drugs in Dermatology},
year = {2026},
volume = {25},
number = {4},
pages = {316--323},
doi = {10.36849/jdd.9441}
}
EUVIMED